Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Copy number alterations in pediatric B-cell precursor acute lymphoblastic leukemia patients and their association with patients’ outcome ; day:26 ; month:11 ; year:2024 ; pages:1-12
Annals of hematology ; (26.11.2024), 1-12
- Creator
-
Abdelfattah, Nesma E.
Elsayed, Ghada M.
Soliman, Amira H.
Ebeid, Emad N.
El Ashry, Mona S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00277-024-06102-2
- URN
-
urn:nbn:de:101:1-2502112117448.087569331729
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Abdelfattah, Nesma E.
- Elsayed, Ghada M.
- Soliman, Amira H.
- Ebeid, Emad N.
- El Ashry, Mona S.
- SpringerLink (Online service)
Other Objects (12)
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia
Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia
Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions
CD19-negative relapse of pediatric B-cell precursor acute lymphoblastic leukemia following blinatumomab treatment
Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia
Survival after blinatumomab treatment in pediatric patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
The role of FOXO1 in B-cell precursor acute lymphoblastic leukemia
Benchmarking miRNA reference genes in B-cell precursor acute lymphoblastic leukemia
DNA methylation holds prognostic information in relapsed precursor B-cell acute lymphoblastic leukemia
Fibroblast growth factor receptor signaling in pediatric B-cell precursor acute lymphoblastic leukemia
Precursor B-cell acute lymphoblastic leukemia presenting as obstructive jaundice: a case report
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia
Cost-Effectiveness of Blinatumomab in Pediatric Patients with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia in France
Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia
Adult acute precursor B-cell lymphoblastic leukemia presenting as hypercalcemia and osteolytic bone lesions